About this Event
Course Co-Chair
Andrea Lora Kossler, MD, FACS
Director, Oculofacial Plastic and Orbital Surgery
Associate Professor of Ophthalmology
Byers Eye Institute at Stanford University School of Medicine
Palo Alto, CA
Faculty
Penny Asbell, MD, FACS, MBA, FARVO
Clinical Professor of Ophthalmology
University of Tennessee Health Science Center
Memphis, TN
Giuseppe Barbesino, MD
Assistant Professor of Medicine, Harvard Medical School, Boston, MA
Associate Physician, Massachusetts General Hospital
Boston, MA
Agenda
8:00 AM
Registration and Breakfast
8:30 AM
Introduction and Pretest
Andrea Lora Kossler, MD, FACS
8:35 AM
Thyroid Eye Disease: Back to Basics
Andrea Lora Kossler, MD, FACS
8:55 AM
Digging Deeper to Improve Differential Diagnosis
Penny Asbell, MD, FACS, MBA, FARVO
9:20 AM
Case Presentation: Differential Diagnosis – Is It Dry Eye or TED?
Giuseppe Barbesino, MD
9:30 AM
Posttest and Question & Answer
9:45 AM
Break
10:00 AM
Around the Orbit With TED Treatment
Penny Asbell, MD, FACS, MBA, FARVO
10:20 AM
Teprotumumab – Can It Change the Treatment of TED?
Andrea Lora Kossler, MD, FACS
10:45 AM
Case Presentation: Treatment of TED
Giuseppe Barbesino, MD
10:55 AM
Question & Answer
11:10 AM
Panel Discussion: Where Do We Go From Here?
Moderated by Giuseppe Barbesino, MD
11:30 AM
Posttest and Question & Answer
11:45 AM
Conclusion
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
Review the pathogenesis, patient risk factors, and nomenclature associated with thyroid eye disease (TED).
Recognize the heterogenous presentation of TED, ocular disorders with similar symptomatology, and the need for an extensive differential diagnosis.
Assess procedures and modalities that aid in the early diagnosis of TED.
Examine case presentations that provide diagnostic and management solutions that can improve the overall outcomes for patients with TED.
Differentiate current medical and surgical treatments for TED, based on their efficacy, benefits, limitations, and ability to improve outcomes in both the active and chronic phase of the disease.
Evaluate the efficacy and safety of insulin-like growth factor 1 receptor (IGF-1R) therapy and how it may be incorporated into practice, safely and effectively.
Summarize the importance of a multidisciplinary team in managing patients with TED, referral to appropriate specialists, and need for patient education about the disease and its management.
The intended audience for this activity is ophthalmologists, endocrinologists, neuro-ophthalmologists, oculoplastic surgeons, optometrists, and other health care professionals involved in the management of patients with TED.
This continuing medical education activity is provided by Vindico Medical Education.
This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Vindico Medical Education designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology's Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting credit.
Faculty, topics, program schedule, and credit hours are subject to change. Recording of any manner is prohibited without written permission from Vindico Medical Education, Office of Medical Affairs and Compliance.
For additional dates/times and information for this series, click here.
Contact Us:
Email: [email protected]
Toll-free: 888-960-0256 Ext. 219 or 476
Outside the U.S.: +(1) 856-994-9400 Ext. 219 or 476
Event Venue & Nearby Stays
JW Marriott Chicago, 151 West Adams Street, Chicago, United States
CAD 0.00